These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 25227555)
21. Distribution of cardiovascular disease and retinopathy in patients with type 2 diabetes according to different classification systems for chronic kidney disease: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study. Pugliese G; Solini A; Bonora E; Orsi E; Zerbini G; Fondelli C; Gruden G; Cavalot F; Lamacchia O; Trevisan R; Vedovato M; Penno G; Cardiovasc Diabetol; 2014 Mar; 13():59. PubMed ID: 24624891 [TBL] [Abstract][Full Text] [Related]
22. Chronic Kidney Disease and Diabetic Retinopathy in Patients with Type 2 Diabetes. Rodríguez-Poncelas A; Mundet-Tudurí X; Miravet-Jiménez S; Casellas A; Barrot-De la Puente JF; Franch-Nadal J; Coll-de Tuero G PLoS One; 2016; 11(2):e0149448. PubMed ID: 26886129 [TBL] [Abstract][Full Text] [Related]
23. Association of Mildly Reduced Kidney Function With Cardiovascular Disease: The Framingham Heart Study. Ataklte F; Song RJ; Upadhyay A; Musa Yola I; Vasan RS; Xanthakis V J Am Heart Assoc; 2021 Aug; 10(16):e020301. PubMed ID: 34387110 [TBL] [Abstract][Full Text] [Related]
24. Chronic kidney disease prevalence and cardiovascular risk in a cohort of patients with type 2 diabetes followed for 10 years in Badajoz (Spain). An observational study. Calvo-Hueros JI; Martín-Hidalgo-Barquero MV; Morales-Gabardino JA; Buitrago F Prim Care Diabetes; 2021 Apr; 15(2):391-396. PubMed ID: 33323354 [TBL] [Abstract][Full Text] [Related]
25. Stronger Association of Albuminuria with the Risk of Vascular Complications than Estimated Glomerular Filtration Rate in Type 2 Diabetes. Hong X; Huang L; Zhang Y; Shen X; Weng S; Zeng F; Zhao F; Yan S Kidney Blood Press Res; 2021; 46(5):550-562. PubMed ID: 34428770 [TBL] [Abstract][Full Text] [Related]
26. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank. Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW; Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159 [TBL] [Abstract][Full Text] [Related]
27. Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial. Heerspink HJL; Jongs N; Chertow GM; Langkilde AM; McMurray JJV; Correa-Rotter R; Rossing P; Sjöström CD; Stefansson BV; Toto RD; Wheeler DC; Greene T; Lancet Diabetes Endocrinol; 2021 Nov; 9(11):743-754. PubMed ID: 34619108 [TBL] [Abstract][Full Text] [Related]
28. Prevalence of positive chronic kidney Disease screening in professional male long haul drivers at risk of cardiovascular Disease in Lagos, Nigeria: a cross-section study. Amadi CE; Mbakwem AC; Kushimo OA; Ajuluchukwu JN; Akinkunmi M BMC Public Health; 2019 Aug; 19(1):1032. PubMed ID: 31370832 [TBL] [Abstract][Full Text] [Related]
29. Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease. Wanner C; Lachin JM; Inzucchi SE; Fitchett D; Mattheus M; George J; Woerle HJ; Broedl UC; von Eynatten M; Zinman B; Circulation; 2018 Jan; 137(2):119-129. PubMed ID: 28904068 [TBL] [Abstract][Full Text] [Related]
30. Effect of Bariatric Surgery on Diagnosed Chronic Kidney Disease and Cardiovascular Events in Patients with Insulin-treated Type 2 Diabetes: a Retrospective Cohort Study from a Large UK Primary Care Database. Alkharaiji M; Anyanwagu U; Donnelly R; Idris I Obes Surg; 2020 May; 30(5):1685-1695. PubMed ID: 32130651 [TBL] [Abstract][Full Text] [Related]
31. Effect of Dapagliflozin on Cardiovascular Outcomes According to Baseline Kidney Function and Albuminuria Status in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial. Zelniker TA; Raz I; Mosenzon O; Dwyer JP; Heerspink HHJL; Cahn A; Goodrich EL; Im K; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Gause-Nilsson I; Langkilde AM; Sabatine MS; Wiviott SD JAMA Cardiol; 2021 Jul; 6(7):801-810. PubMed ID: 33851953 [TBL] [Abstract][Full Text] [Related]
32. Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25). Yokoyama H; Araki S; Haneda M; Matsushima M; Kawai K; Hirao K; Oishi M; Sugimoto K; Sone H; Maegawa H; Kashiwagi A; Diabetologia; 2012 Jul; 55(7):1911-8. PubMed ID: 22476921 [TBL] [Abstract][Full Text] [Related]
33. Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial. Jongs N; Greene T; Chertow GM; McMurray JJV; Langkilde AM; Correa-Rotter R; Rossing P; Sjöström CD; Stefansson BV; Toto RD; Wheeler DC; Heerspink HJL; Lancet Diabetes Endocrinol; 2021 Nov; 9(11):755-766. PubMed ID: 34619106 [TBL] [Abstract][Full Text] [Related]
34. The Association Between Kidney Disease and Diabetes Remission in Bariatric Surgery Patients With Type 2 Diabetes. Friedman AN; Wang J; Wahed AS; Docherty NG; Fennern E; Pomp A; Purnell JQ; le Roux CW; Wolfe B Am J Kidney Dis; 2019 Dec; 74(6):761-770. PubMed ID: 31331758 [TBL] [Abstract][Full Text] [Related]
35. Prevalence and coprevalence of chronic comorbid conditions in patients with type 2 diabetes in Catalonia: a population-based cross-sectional study. Mata-Cases M; Franch-Nadal J; Real J; Cedenilla M; Mauricio D BMJ Open; 2019 Oct; 9(10):e031281. PubMed ID: 31662386 [TBL] [Abstract][Full Text] [Related]
36. Value of Estimated Glomerular Filtration Rate and Albuminuria in Predicting Cardiovascular Risk in Patients with Type 2 Diabetes without Cardiovascular Disease. Weerarathna T; Liyanage G; Herath M; Weerarathna M; Amarasinghe I Biomed Res Int; 2018; 2018():8178043. PubMed ID: 30729117 [TBL] [Abstract][Full Text] [Related]
37. High-normal albuminuria is strongly associated with incident chronic kidney disease in a nondiabetic population with normal range of albuminuria and normal kidney function. Okubo A; Nakashima A; Doi S; Doi T; Ueno T; Maeda K; Tamura R; Yamane K; Masaki T Clin Exp Nephrol; 2020 May; 24(5):435-443. PubMed ID: 32076888 [TBL] [Abstract][Full Text] [Related]
38. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes. Wada T; Haneda M; Furuichi K; Babazono T; Yokoyama H; Iseki K; Araki S; Ninomiya T; Hara S; Suzuki Y; Iwano M; Kusano E; Moriya T; Satoh H; Nakamura H; Shimizu M; Toyama T; Hara A; Makino H; Clin Exp Nephrol; 2014 Aug; 18(4):613-20. PubMed ID: 24132561 [TBL] [Abstract][Full Text] [Related]
39. Association between decreasing estimated glomerular filtration rate and risk of cardiac conduction defects in patients with type 2 diabetes. Mantovani A; Rigolon R; Turino T; Pichiri I; Falceri A; Rossi A; Temporelli PL; Bonapace S; Lippi G; Zoppini G; Bonora E; Byrne CD; Targher G Diabetes Metab; 2018 Dec; 44(6):473-481. PubMed ID: 30195089 [TBL] [Abstract][Full Text] [Related]
40. Determinants of early chronic kidney disease in patients with recently diagnosed type 2 diabetes mellitus: a retrospective study from the Taiwan Diabetes Registry. Yeh YK; Lin KH; Sheu WH; Lo SH; Yeh YP; Huang CN; Hwu CM; Lu CH BMC Nephrol; 2024 Apr; 25(1):133. PubMed ID: 38622535 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]